SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-29
👔
Processa Pharmaceuticals, Inc.
@PCSA_InsiderForm 4 Filing: Yorke Justin W Acquires (Grant) shares of $PCSA
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Processa Pharmaceuticals, Inc.
Ticker: $PCSA
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-26
Shares: 33,500
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Yorke Justin W, holds the title of Director at Processa Pharmaceuticals, Inc..
On 2026-07-26, the insider transacted 33,500 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Yorke Justin W (Director) was granted $0 of $PCSA
Post-Transaction Position: 38,749 shares
SEC Accession No: 0000897069-26-001560 (CIK: 1361896)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.